BNKL (Bionik Laboratories) Change In Inventory: $0.08 Mil (TTM As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BNKL Bionik Laboratories Corp BNKL
12 GF Score
Price $0.00
View Full Analysis

What is Bionik Laboratories Change In Inventory?

Bionik Laboratories BNKL -99.00% 12 Change In Inventory is $0.08 Mil as of Mar. 2023. GuruFocus rates BNKL with a GF Score™ of 12/100.

Bionik Laboratories's change in inventory for the quarter that ended in Mar. 2023 was $0.11 Mil. It means Bionik Laboratories's inventory declined by $0.11 Mil from Dec. 2022 to Mar. 2023 .

Bionik Laboratories's change in inventory for the fiscal year that ended in Mar. 2023 was $0.08 Mil. It means Bionik Laboratories's inventory declined by $0.08 Mil from Mar. 2022 to Mar. 2023 .

Bionik Laboratories's Total Inventories for the quarter that ended in Mar. 2023 was $1.03 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bionik Laboratories's Days Inventory for the quarter that ended in Mar. 2023 was 402.31.

Inventory Turnover measures how fast the company turns over its inventory within a year. Bionik Laboratories's Inventory Turnover for the quarter that ended in Mar. 2023 was 0.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bionik Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2023 was 2.17.


Bionik Laboratories  (OTCPK:BNKL) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bionik Laboratories's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1.089/0.247*365 / 4
=402.31

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bionik Laboratories's Inventory Turnover for the quarter that ended in Mar. 2023 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bionik Laboratories's Inventory to Revenue for the quarter that ended in Mar. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bionik Laboratories Change In Inventory Related Terms


Bionik Laboratories Change In Inventory Historical Data

* Premium members only.

The historical data trend for Bionik Laboratories's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionik Laboratories Change In Inventory Chart

Bionik Laboratories Annual Data
Trend Dec14 Dec15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.17 -0.65 0.33 -0.54 0.08

Bionik Laboratories Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.31 -0.23 0.03 0.17 0.11
BNKL
12GF Score
Bionik Laboratories Corp BNKL
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bionik Laboratories Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.08 Mil mean?
Bionik Laboratories (BNKL) has a Change In Inventory of $0.08 Mil as of Mar. 2023. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Bionik Laboratories and its competitors.
Is Bionik Laboratories' Change In Inventory too high?
Bionik Laboratories' current Change In Inventory is $0.08 Mil. Overall, Bionik Laboratories has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bionik Laboratories' Change In Inventory compare to ARPC and GRST?
Bionik Laboratories' Change In Inventory of $0.08 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Healthcare Providers & Services company?
A good Change In Inventory depends on the Healthcare Providers & Services industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Bionik Laboratories and its competitors. Bionik Laboratories's current Change In Inventory is $0.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionik Laboratories stock overvalued right now?
Bionik Laboratories (BNKL) has a current Change In Inventory of $0.08 Mil. The current Change In Inventory is $0.08 Mil. Bionik Laboratories' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Bionik Laboratories (BNKL), the current Change In Inventory is $0.08 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bionik Laboratories Business Description

Address 80 Coolidge Hill Road, Watertown, MA, USA, 02472
Bionik Laboratories Corp is a healthcare company focused on improving the quality of life of millions of people with neurological or mobility impairments by combining artificial intelligence and robotics technology to help individuals from hospital to home regain mobility, enhance autonomy, and regain self-esteem. The company uses artificial intelligence and machine learning technologies to make rehabilitation methods and processes smarter and more intuitive to deliver a greater recovery for patients with neurological or mobility impairments. Its products The InMotion ARM, and InMotion ARM/HAND are robotic therapies for the upper limbs.
12GF Score

Get the complete analysis for BNKL

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price